35 Burst results for "Astra Zeneca"

EU Asks Belgian Court to Fine AstraZeneca

Monocle 24: The Briefing

01:59 min | 2 months ago

EU Asks Belgian Court to Fine AstraZeneca

"The european union and vaccine producer. Astrazeneca are attempting to settle their differences in brussels court today. The e contends that astrazeneca has been slow to deliver the doses of covid nineteen vaccines was contractually obliged to and that at least fifty million doses the e. You should have had were sent elsewhere. Astrazeneca unsurprisingly disputes. This cynical souls have suggested that. The eu is seeking to deflect blame for a generally slow rollout of covid nineteen vaccines especially when measured against the progress of recent. You abscond e the united kingdom. Well joining me now. From brussels fronts twentyfold europe editor. Catherine nicholson She's joined also by independent legal expert. Get vancouver who is joining us from leuven catherine first of all to the basics of the case itself. What is the use case here in what of i hoping to gain from this i say the european commission signed a contract with seneca supply Vaccine doses at the end of august last year and it paid two hundred twenty four million euros astrazeneca a full ingredients for these vaccines in september of twenty twenty so the commission is saying that contracts to astra zeneca to deliver three hundred million indexes affects seem by the end of june this year But it's now expecting to receive just fifty million even the listens per we remember that astrazeneca said earlier in the yet they have some production problems therefore saving issues as we know with experts being restricted from various places around the world the european commission. Oversees saying this is not what they contracts it. That's their arguments And they are demanding. That's more doses be delivered And it's essentially arguing that astrazeneca's failed to honor contractual commitments. To deliver vaccine doses. On the other hand astra zeneca says that this case is without

Astrazeneca Brussels EU Catherine Nicholson Seneca Supply Vaccine Leuven European Commission United Kingdom Vancouver Europe
A Look at the Science Behind Vaccines and Blood Clots

The Big Story

00:45 sec | 3 months ago

A Look at the Science Behind Vaccines and Blood Clots

"Is the big story. Roxanne kimsey independent science journalist who dove deep into the astra zeneca and johnson and johnson. Blood clotting shoe for the atlantic. Hey roxanne has it going. It's going well i'm I'm excited to talk about this. Because i feel like this is a way more complex Medical issue then. It's often presented as is that accurate. Oh i mean absolutely. I think that with each day that goes by a new layer is added and the average person's kind of left scratching their head and thinking. What does this mean for me but absolutely the science is is is getting deeper by the day and it's it's great in a way because we're learning so much about vaccines that we never knew. Maybe let's

Roxanne Kimsey Astra Zeneca Johnson Roxanne Atlantic
Australia and Greece Recommend Alternative Vaccines for Young People

Up First

01:55 min | 4 months ago

Australia and Greece Recommend Alternative Vaccines for Young People

"Australia and greece are the latest countries to recommend alternatives to the astra zeneca cova vaccine for young people after researchers found more rare but potentially fatal blood clots linked to the vaccine. European officials have identified roughly two hundred clots among a million people who shaved astra zeneca shots in europe in the uk. Npr's jason bogosian has been following the story and he joins us now for an update. Good morning good morning jason Some of the new research was published. Just yesterday what does it say what. We still don't know exactly what's happening in these patients. The papers in the new england journal of medicine. They look at sixteen cases in norway. Germany and austria. And here's what they found. The symptoms begin about a week to fourteen days. After the immune ization patients started out with these really severe headaches. Muscle aches swelling. Nine of the sixteen died and most of them were young women in their twenties and thirties. Yikes do you know why. At this point it's too early to tell why predominance among women it may be due to the fact that norway was using astrazeneca for healthcare workers who lean towards predominantly women and using pfizer to vaccinate. It's older populations that might have things bit. Initially european regulators said the rates of this calling disorder. Were no higher than what you'd see in the general population. But they've changed that now they're saying yes it does appear that in roughly one in a hundred thousand people vaccinated with astra zeneca. This serious side. Effect could occur. We should note that the astra zeneca vaccine is not authorized yet here in the united states correct but our other countries with this new information. Still gonna use it. Well some are switching. How they're using it. They're offering alternatives to the younger people and trying to use astrazeneca more with older groups up but many countries really don't have a choice. Astra zeneca is the vaccine. Much of the world is banking on

Astra Fatal Blood Clots Jason Bogosian Astra Zeneca Norway Greece NPR New England Journal Of Medicin Australia Jason Austria Europe Headaches UK Germany Pfizer United States
Officials rush to defend AstraZeneca Covid vaccine after UK, EU blood clot guidance

Today in Focus

02:05 min | 4 months ago

Officials rush to defend AstraZeneca Covid vaccine after UK, EU blood clot guidance

"The oxford astrazeneca vaccine under uncomfortable scrutiny medicines regulators in the uk and the eu have judge that its benefits outweigh any possible risks. But they haven't ruled out a causal link between the vaccine and rare blood clot conditions in a tiny number of recipients resulting. This week in britain's regulator the are recommending alternative vaccines be given two hundred thirty s. All of which is worrying when it comes to competence in this back saying because as the observers science editor robin the key points out the stakes are incredibly high. It is the vaccine which the world depends. Because it's so easy to store and distribute a little cost so it's an incredibly important vaccine for the planet we might in the west. Get away with visors. Madonna's leaves astrazeneca. There's no doubt about it from the guardian. I'm a niche kristalina. Today in focus understanding the risks and rewards of the astra zeneca vaccine robin. When did this start. When did they first notice. But there might be a link between the vaccine and blood clubs. I miss in scandinavia at the leg. Ego muffled memento through dot com the live it will be weakening at astrazeneca seneca walks in norway and denmark. A proper schooners vaccine and they've begun to spot. These links of these tastes on gemini finds. Stop stop stuff. The in china from ministers bondi influence middle astrazeneca forces tiber asthma also advising defiant britain finds cases the british medicines regulator the hra says. It's like done defied. Thirty cases of red blood clots and people who've had the astra zeneca corona virus vaccine.

Oxford EU Britain Astrazeneca Astrazeneca Seneca Robin UK Astra Madonna Scandinavia Norway Denmark Asthma China HRA Red Blood Clots
COVID-19 vaccine reaches world's far corners

UN News

01:17 min | 4 months ago

COVID-19 vaccine reaches world's far corners

"More than one. Hundred countries and economies have now received cave nineteen vaccines through the un partnered equitable corona virus. Busting scheme kovacs. The first delivery of life saving jobs arrived in ghana on the twenty fourth of february announcing the news on thursday the world health organization. Who said that more than thirty. Eight million doses of astrazeneca fire and serum institute of india have being transported globally. So far the aim is to deliver at least two billion doses of vaccines in two thousand and twenty one. In particular to developing countries. The development comes as who and other health regulators reaffirmed the overwhelming value of the astra zeneca or a covid nineteen vaccine amid ongoing concerns about clotting events among a very small number. You've had the job in statements on wednesday evening. Who's global advisory committee on vaccine safety. The european medicines agency and the uk's regulator or concluded that the benefits of taking the vaccine outweigh the very rare potential risks more than one hundred ninety million doses of the astros. Zenica vaccine have been administered today but only one hundred eighty. Two cases of clotting have been reported. Who said as it advised countries to continue to vaccinate with the as at vaccine not that it had saved millions of lives and prevented serious illness

Astrazeneca Fire And Serum Ins Kovacs Astra Zeneca World Health Organization Ghana UN Jobs European Medicines Agency Zenica Astros UK
COVAX Reaches Over 100 Economies, 42 Days After First International Delivery

UN News

01:17 min | 4 months ago

COVAX Reaches Over 100 Economies, 42 Days After First International Delivery

"Than one hundred countries and economies have now received covid nineteen vaccines through the un partnered equitable corona virus. Busting scheme kovacs. The first delivery of life saving jobs arrived in ghana on the twenty four of february announcing the news on thursday the un world health organization. Who said the more than thirty eight million doses of astrazeneca pfizer biotech and serum institute of india had been transported globally so far kovacs aims to supply vaccines to all those requested them. In the first half of this year the development comes as who and other health regulators reaffirmed the overwhelming value of the astra zeneca or as ed covid nineteen vaccine amid ongoing concerns about clotting events among a very small number had the job in statements on wednesday evening the. Who's global advisory committee on vaccine safety. The european medicines agency and the uk's regulator all concluded that the benefits of taking the vaccine outweigh the very rare potential risks. More than one hundred and nine hundred million doses of the astra zeneca vaccine have been administered. Todate but only one hundred eighty two cases of clotting have been reported. Who said its advice to countries to continue to vaccinate with the as at vaccine noting that it has saved millions of lives and prevented serious illness

Kovacs Un World Health Organization Astrazeneca Pfizer Biotech Serum Institute Ed Covid Ghana Astra UN European Medicines Agency India UK
Blood Clots Reportedly 'Very Rare' Side Effect of AstraZeneca Vaccine

NPR News Now

01:01 min | 4 months ago

Blood Clots Reportedly 'Very Rare' Side Effect of AstraZeneca Vaccine

"Does believe that there is a possible link between the astra zeneca co covid vaccine and very rare but potentially fatal blood clots. Npr's jason boubyan reports that the european drug regulators says that boycotts must now be listed as a possible side effect. The safety committee of the european medicines agency analyzed eighty six cases of blood clots. That occurred in people up to two weeks after getting the astrazeneca shot and we have concluded that there is indeed a possibility of a very rare event that might occur. That's dr sabine. Strauss the head of the safety committee. She says the unusual immune reaction appear similar to a rare clotting reaction to a blood thinner called heparin. there have been at least eighteen. Potentially vaccine related deaths among the twenty five million people immunized with astra zeneca in europe stresses that with thousands of people dying every day from covid the benefits of the asiatic vaccine far outweigh the potential risk from this rare. Immune reaction jason on. Npr news this

Astra Zeneca Co Fatal Blood Clots Jason Boubyan Safety Committee Of The Europe Dr Sabine Astra Zeneca Safety Committee NPR Strauss Europe Npr News Jason
South Africa Under Fire Over Resale of AstraZeneca Vaccines

NPR News Now

00:41 sec | 4 months ago

South Africa Under Fire Over Resale of AstraZeneca Vaccines

"Africa has sold the one million doses of the astra zeneca corona virus vaccine that got earlier this year after a study showed it offers minimal protection against mild and moderate cases of the south african variant but ishmael fundy globe reports. Many are criticizing the sale. Many south africans argue the vaccine could have been given to high risk individuals as it would protect them against severe disease. The government opted to roll out the country's vaccination program using johnson and johnson vaccine so africa has the highest number of recorded covid nineteen cases and debts on the african continent. Ishmael fantastic love reporting

Ishmael Fundy Globe Astra Africa Johnson Ishmael
South Africa sells AstraZeneca doses to other AU nations

NPR News Now

00:39 sec | 4 months ago

South Africa sells AstraZeneca doses to other AU nations

"The one million doses of the astra zeneca corona virus vaccine. Got this year after a study showed it offers minimal protection against mild and moderate cases of the south african variant but ishmael phoned equal reports. Many are criticizing the sale. Many south africans argue the vaccine could have been given to high risk individuals as it would protect them against severe disease. The government of to roll out the country's vaccination program using the johnson and johnson vaccine so lucky guy has the highest number of recorded covid nineteen cases and debts on the african continent ishmael and equal reporting in. Florida

Astra Ishmael Johnson Florida
Vaccines vs Variants: Will They Work?

Science Vs

01:50 min | 4 months ago

Vaccines vs Variants: Will They Work?

"Today on the show. Where pinning facts against visor and medina and johnson and johnson and astra zeneca. Yes more and more of us getting out shots and so we want to know. Will these vaccines save us or is the virus about to outsmart us again. Hey science versus. I got my first Ouchi a few weeks ago. We asked signs vessels listeners. What it was like to finally get the job. I received the first dose of my pfizer vaccine. My first dose of the moderna vaccine. Johnson and johnson one and john. When they gave me the shot. I was like tell me. When it's done in there like we already did it. And over and over again we had one word to describe how people felt relief relief. Just the relief and started crying in the waiting area. That just feels like word stepping out from under the dark cloud. I feel like i can actually breathe again. But at the same time there was a lot of confusion after all cases at taking up in the us and other parts of the world. I'm still nervous about that. Return to normal when they get full. Immunity is it safe to do exactly if i'm still nervous about possibly carrying the virus and giving it to someone unvaccinated and meanwhile we're hearing more and more about new mutations in this virus but some are saying can make it more deadly and help it spread foster and now people are wondering. Wait a sec if this virus is changing these vaccines we just got even gonna work.

Astra Zeneca Johnson Ouchi Medina John Confusion United States SEC
Clinical trials underway to test jab efficacy for children in the UK

The Leader

02:28 min | 4 months ago

Clinical trials underway to test jab efficacy for children in the UK

"Some queued for hours outside wall substitute library for walk. In short of the coluna virus vaccine. Three thousand jobs were given here during the day earlier. This week it was announced that fifty seven percent of all adults in the uk been given at least one shot but now could the nation's children also joining the lines. Trials are apparently on the way. Our deputy political editor. Nicholas cecil has stored nicholas. How young are we talking about here. Well at the moment scientists and health experts in bristol. The building children's vaccine said they have a study underway involving children who are teenagers. And this is a study using the astra zeneca jab. They're expecting shortly to be given the go ahead to start recruiting younger children as young as five and the reason why they're doing these trials is that so far all. The clinical trials have been adults to check that the vaccine was safe and worked in adults. And now they're checking out with it. It'd be equally safe and effective for for for children for people under eighteen benegas. Do we need to give children a virus facts. Because i thought you know the whole point of them. Going back to school was because young people don't get the serious effects of covid nineteen if the contract. This is a very interesting ethical question children as you say if they do get grown virus they are very unlikely to get the disease severely. But there's a big issue here of nuts about the circulation of the virus so this study will look at whether the vaccine works in children and then the the experts expect decision by the government in the summer about whether to start vaccinating children and professor. Adam finn who's from bristol university one of the leading experts on this. He was explaining that to vaccinate children just for the benefit of other people that that could be questionable and he would feel uncomfortable about that but he explained that actually if vaccinating children meant that the disease was kept under control and that meant that schools could reopen safely in september then there would be a benefit to children and therefore actually giving the jabs to children we would be beneficial only to them but also society

Nicholas Cecil Benegas Astra Nicholas Bristol UK Adam Finn Bristol University
Astrazeneca vaccine in US raises hopes

The Naked Scientists

02:04 min | 4 months ago

Astrazeneca vaccine in US raises hopes

"This week has covid. Nineteen cases continue to fall across the uk. They are at the same time surging in europe partly as a result of the spread of the kent. Variant that is now becoming the dominant circulating strain of the virus in many eu countries. The other factor is low levels of corona vars vaccination that have so far been achieved across the eu block. Some of that stems from skepticism. Any eu countries about the effectiveness of the astra zeneca vaccine. So maybe that will be about to change now. Thanks to the announcement of another successful trial of the vaccine. This time in the us astrazeneca have slightly revised their numbers since they made the trial results public. But they're still very encouraging. Chris spoke to university of kent virologists. Jeremy rothman to his reaction. I asked him whether a year on from the uk. I entering a lockdown. He expected us to be in this situation. We are today absolutely not. There's a lot that we had an idea of what was coming in terms of the severity and the need for strong action. But the fact that we are still experiencing lockdowns that. We've spent a large portion of the year in lockdown in dramatic restrictions. And we still do not have a solid plan of how we are going to get out of. This is really beyond belief to me. What did you think would happen this time last year when we watched boris johnson. Deliver that press conference when everyone was just glued to the tv and we'll fell down our spines. Where did you think it would end and win. I wasn't sure what i was hoping was that we would have lockdown and that that would drive cases down now that that absolutely did happen but what i had been waiting for. That didn't happen was that we would use that period of time to build and reinforce the infrastructure needed when we got out of the locked out

EU Jeremy Rothman UK Astra Astrazeneca University Of Kent Europe Chris Boris Johnson United States
"astra zeneca" Discussed on Progressive Talk 1350 AM

Progressive Talk 1350 AM

07:32 min | 4 months ago

"astra zeneca" Discussed on Progressive Talk 1350 AM

"Astra Zeneca and their vaccine has been on a roller coaster ride this week. As we learned there shot is 76% effective against symptomatic Open 19. Monday was 79% then U. S. Officials said they were using outdated data and finally came back with the correction. Karen Wine Child Health Care reporter at USA Today. Wonders for the difficult rollout. This vaccine. It's news without the noise. Let's died it were consoling with our allies and partners. And There will be responses if they choose to escalate. Um, way will respond accordingly. Joining us now is Julia Manchester Political reporter at the hill. Thanks for joining us, Julia Think stabbing me. President Biden had his first news conference. Nothing new or really groundbreaking. I don't think came out of it, but it was the first one. I think we're 65 days in office so far, and he had the first one first off because there was a lot of concern going into it. There was gonna be any gaffes by the president. If he was going to stumble, and then how the media was going to treat him Also, you know, this is obviously coming after The contentious relationship that President Trump had with the media. So Julian, let's start there any big gas and how was he with reporters? And for the more most part, there weren't really any big gaps. We know that on the issue of the filibuster, CNN's Caitlin Collins seemingly tripped him up a little bit when he seemed toc suggest, maybe more than he normally would. That the filibuster is archaic and that you'd like to see it go by the wayside. So that was very interesting but big takeaway and I think a criticism but many members of the press have been facing is that there was not a question on the Corona virus pandemic and said, We Saw reporters focusing on issues like the filibuster, gun control and obviously immigration, and we know that Biden's chief of staff, Rahm claim is actually you've seen him. Retweeting and other members of fight and Stuff. Retweeting that criticism of the press for not talking about the global pandemic obviously bite and wanted to be talking about the global Can't Donaghy and out from that press conference that he is going to increase his original 100 million shots and the his 1st 100 days. 200 million shots in his 1st 200 days or 100 days. He would obviously be wanting to talk about that more. Instead, he was forced to confront the issue about the lack of unity in Congress as well as a growing crisis. US southern border. There was a lot of time spent on immigration and the crisis at the border migrant Children there and overcrowding. How did that go? Because there was things he blamed. The previous administration for dismantling some of the process is there and saying we're in a rebuilding process, trying to get back up there, and he did also commit to more transparency there. But on his own timeline, he said. Not yet when we're ready when I get my plan implemented basically Absolutely. This is a tough issue and was a tough issue for Biden to really have to confront because remember during the 2020 presidential campaign, he spent so much time along with the other Democratic candidate, hammering President Trump for the same situation at the border for seeing unaccompanied minors being captain really bad conditions for having Tomo deal with the growing number of people arriving at the border, So we've seen that his Administration has been very slow to call it a crisis. They have used the term situation despite the fact that they have already sent FEMA down there to deal with it. But I think Biden was very careful. Not necessarily lay blame 100% to President Trump's administration. But there was a notable moment when he was asked about. Policy and reporter talked about how they talk to a family. That said, Look, he talked to the family that arrived at the border, and they said they came because they thought for the Biden administration would be more sympathetic and empathetic to their cause, not seemingly made him a little emotional, But he did not want to necessarily give away that his immigration policy is why there is this growing crisis of the border. What did we hear when it came to foreign policy, China and competition with China came up troops leaving Afghanistan and there's a May 1st deadline set by the Trump administration, he said. We probably won't meet that and then North Korea. They've launched a serious of missiles recently, President Biden said. We would respond accordingly. If things get escalated. Yeah, on the issue of North Korea. That's very interesting because this is the first missile test from North Korea of the Biden administration, and it is in a way. I think Pyongyang really trying to test bite and temperament on this issue, and he said they would respond accordingly. So he's really trying to put up this tough crunch from Washington against Pyongyang. I think you also saw that with China as well. We've seen that relations between China and the United States. Have definitely intensified and not a great way. In the past couple of weeks, you saw the secretary of state Blanken really had to head in person with his Chinese counterpart in Alaska last week, so that's definitely something divided Administration is very well aware of And as I mentioned to the just the Afghanistan thing I think we have 2500 troops there right now and about 6500 NATO troops who are seeing what the U. S is going to do before they move any troops. He said that he can't see them being there next year but still probably won't hit that made first deadline. In terms of Afghanistan. I think you know, this is obviously an area where bide and has been focused before as vice president. And right now I think there's a risk of the child band really gaining momento em and gaining influence and power in Afghanistan. So this is summon area where Biden wants to be extremely, extremely cautious to not leave a big vacuum. Like what happens during the Obama administration, really in Iraq, where when they pull out troops out of Iraq, you saw that vacuum emerge and you saw Isis? Emerged. At the same time, though we know that these long wars are conflicts that the United States has been involved in in the Middle East and Western Asia. They're deeply unpopular with Americans, so it's very, very difficult situation that supplied administration finds itself in there. 65 days in this is the first news conference looking forward. They already asked President Biden if he's gonna be running in 2024. He said he expects to previously had said he he might only stick around for one term that was never set in stone. But he says that he would expect Vice President Kamila Harris to be his running mate. Also We know that Biden is the oldest president ever elected. We know that the president see no matter what age you are is a physically and mentally taxing job. So after four years of it, you know it's understandable why someone that old would want to retire with want to step back. However, he's giving no indication of that. However, I think this week with him handing the situation at the border and giving control of that shoes, Vice President Harris that shows that you're still very much trying to get her ready. To take that leadership role. The question is, though, when she'll be able to take on that mantle of leading the Democratic ticket. Julia Manchester political reporter at the Hill, thank you very much for joining us. Thank you for having me.

Caitlin Collins 79% Julia Congress Alaska 65 days Middle East 76% 100% 2024 CNN 2500 troops 100 days Julian May 1st last week Iraq Western Asia FEMA Monday
AstraZeneca Releases Updated Covid-19 Vaccine Data Showing 76% Efficacy

Squawk Pod

01:29 min | 4 months ago

AstraZeneca Releases Updated Covid-19 Vaccine Data Showing 76% Efficacy

"This was seriously weird. Turn of events for astrazeneca. This week monday morning. We got the highly anticipated face. The results from its. Us trials seventy nine percent efficacy which came in better than expected but later that night at about midnight dr found institute released a statement saying the oversight board said those were data so now astrazeneca has given us the updated results just two days later and the numbers. They really didn't change too much now. Seventy six percent overall efficacy against symptomatic disease the efficacy against severe disease state and one hundred percent in people over sixty five and actually went up five points to eighty five percent and they did have a lot more cases to count here one hundred ninety as of today's results including eight severe cases strengthening that finding from one hundred forty one and five severe cases on monday. Guys how to folks looking at this after seeing kind of rollercoaster. We've seen this week and just saying the vaccine looks good. But the communications have just been awful. Dr not had bedell tweeting quote at this point. I'll just wait for the fda submission packet just to avoid any more roller coaster rides and a guys. A lot of people will be looking forward to seeing those data when astra zeneca files which they had said would be in the first half of april with the fda then three weeks later we should see fda's analysis of those data and we'll get to look at all of it itself but this has just been a weird ride made even more weird by the fact that these updated data didn't really change that

Astrazeneca Dr Found Institute Symptomatic Disease FDA Bedell Zeneca United States Astra
Export-control panel: the EU meets on vaccines

The Economist: The Intelligence

01:21 min | 4 months ago

Export-control panel: the EU meets on vaccines

"Today. European union leaders will hold a virtual summit to discuss improvements to the bloc's vaccine roll out. The most contentious topic will be plans to increase europe's ability to block exports of vaccines. The proposed legislation was unveiled yesterday by the train chief valdez dombrowski's commission has adopted and implementing revelation To adopt an expert authorization mechanism for vaccine was aim of preserving security of our supply chains. The wording is general of the intent specific. The proposal comes as a battle plays out between the eu and the british swedish company astra zeneca which has been accused of failing to honor its supply contract with europe. The move marks a sharp escalation in the us response to a floundering vaccination rollout at home beset by delivery delays supply issues and a third wave of the disease. Britain would be hard hit by those new rules because so far. It's benefited the most. From europe's vaccine exports but yesterday britain and the e u issued a joint statement. Aiming for a win win situation that would boost supplies for both that might sound like a cooling of tensions but the vaccine row has been long in coming and marks another jolt on an already bumpy road to a post brexit relationship.

Valdez Dombrowski European Union Astra Zeneca Europe Britain United States
AstraZeneca Releases Fuller Data Backing Its Vaccine

WSJ What's News

00:42 sec | 4 months ago

AstraZeneca Releases Fuller Data Backing Its Vaccine

"Additional data from astra zeneca says it's kobe. Nineteen vaccine is seventy six percent effective. According to a fuller analysis of trial data released yesterday. The drugmaker came under pressure earlier this week. After provided preliminary trial data showing its vaccine was seventy nine percent effective. An independent monitoring board said the data were out of date raising concerns of us officials. Astrazeneca's latest results were largely consistent with the preliminary findings reported on monday. The company said it would submit the findings for peer review and publication in coming weeks and request authorization of the vaccine from the us food and drug

Astrazeneca United States
NIH Statement Raises Questions About AstraZeneca's Vaccine Data

NPR's Business Story of the Day

01:36 min | 4 months ago

NIH Statement Raises Questions About AstraZeneca's Vaccine Data

"Company to work with the dsm be. That's us to review the efficacy data and ensure the most accurate up-to-date efficacy data can be made public as quickly as possible. Those are such long sentences that i feel. We need to translate a little bit here so we were told yesterday. Seventy nine percent efficacy which is pretty good for a vaccine so that sounds good but then there is this concern expressed suggesting that maybe if you look at the test results different way you don't see seventy nine percent astra zeneca saying in response to that. Well that's exactly right so there so the dnb is saying look at all the day to look at the newest data and the company. Just put out a release said the numbers published yesterday. Were based on. A pre specified interim alice's with a data cutoff of february seventeenth. So they're looking back at data that was collected as of february seventeenth and the dsm be seems to be saying that between then and now we have more data which makes your efficacy numbers. Not look as good. That seems to be what's happening here. I think we can interpret that as well. That would mean does it. Not that a few more people in this study got sick. Got covert and so the seventy nine percent rape didn't quite hold up right. They got sick and they got sick in the vaccine arm of the study. Not the placebo arm of the study. That's why the numbers don't look as good so we still think this is a pretty good vaccine but maybe not seventy nine percent. What are the locations for actually getting this approved in the united states. Exactly it's still a good vaccine. Not quite as good and this is just a strange turn. And it'll be up to the fda to analyze

Zeneca Astra Alice United States FDA
A Look Inside The World's Biggest Vaccine Maker

Short Wave

06:28 min | 4 months ago

A Look Inside The World's Biggest Vaccine Maker

"So rosa palm trees here green lawns. A little bit like a college campus riding in a golf cart up to the factory. Your some of these are the migos month. Rubella reviews vaccine serum institute of india was already the world's biggest vaccine manufacturer even before this pandemic the company says two thirds of all children in the world. Get its vaccines and most of them are made here. At a sprawling factory complex in western india inside conveyor belts with all these tiny little vial weasing going for automatic resilience section automatic. Visual inspection is inspecting me europe machine. It's a high tech operation but look outside the factory window and you see a reminder of this companies more humble roots horses in the nineteen sixties. This was a farm breeding race horses and one day. One of the horses got bitten by a snake. Suresh giada serums executive director. Explains what happened next. Bimbos do the lanes. Were not working great in india so he could not get their disney. We could not get anti snake venom serum in time the horse died but it's owner had an idea you said yesterday why not start making it ourselves. So the serum institute of india was born. It began making serums against tetanus and snake venom and leader added vaccines against all sorts of childhood diseases. They specialize in generic versions at low profit margins and export to one hundred and seventy different countries last spring. A tiny package arrived here by career from oxford university in england to the very small. While is one in chief scientist. Shali graham describes what was inside components of a viral vector vaccine against the corona virus serum scrambled to start mass producing them immediately in huge floor to ceiling stainless steel vats of the one. Embryonic human embryonic kidney selling yeah scientists petty ready recalls how he was developing other vaccines these fats when his supervisor told him to quickly convert everything over to the corona virus vaccine while under lockdown as the pandemic exploded it was difficult to follow very strict rules of solution during this People to do overtime. This was before. Clinical trials showed that the oxford astrazeneca vaccine would work. It was a gamble with so much at stake. He says everybody's waiting for the all mankind waiting. The whole world is waiting for it to this winter. When trials finally proved this vaccine did indeed work is celebrated internally. Not like party or something but we had that moment of joy gonna champagne. No no serum hopes to soon be churning out a hundred million doses per month of this one vaccine on top of all the other vaccines they're still producing here. The oxford astra zeneca. Formula is particularly attractive to india and other low and middle income countries. Because it needs just regular refrigeration not subzero temperatures. This is for storage area. The capacity of seventy million dollars. So what we're looking at here is enough to vaccinate. Whole countries is ongoing process of building out of cold storage along these conveyor belts and out to sixty eight country so far racing against russia china. In what some are calling vaccine. Diplomacy india's huge capacity is attracted interest from the so called quad. The us japan. Australia and india. They announced financing to help another indian producer make a billion more doses of another co vaccine but while indian manufacturers are partnering with global pharmaceutical companies. The indian government is challenging pam at the world trade organization. There is an agreement that binds all wto members to certain levels of protection for intellectual property. Twenty year patents. Regional thrashers legal scholar at the global development policy center in boston. She explains how india and south africa are asking the wto to suspend those patents. Cova vaccines so that companies like serum can crank out generic versions quickly and in certain countries the majority of the population won't be vaccinated for something like five years that gives those viruses a long time to mutate. So the argument they're making is not. Hey look out for us but more this is in the interest of all of us. Everyone serums executive director. John says he supports that effort at the wto watery required is a vaccine today. Not tomorrow you want to stop the disease and stop it sprayed and that can happen. Only if there is no restriction on using technology many global health experts agree. The pope has said he does too but some companies including astrazeneca have pledged to sell vaccines at cost without profit and suspending. their patents. They say is not the answer it would kill innovation and would not speed up distribution bottlenecks more to do with supply chains than access to the vaccine technology itself. Both sides of this debate are over emphasizing. The role of patents. Daniel hamill is a law professor at the university of chicago. He says the serum institute success chose a middle path. It got a license from astrazeneca. It's been able to mass produce vaccines within the current regulatory environment ensures the potential licensing arrangements without cancelling patents ceremonies if you're disabled to gain rights to make vaccines on a large scale. That's a good thing could serums factory. As vials of corona virus knock scenes wiz off conveyor belts inside chief scientist ms. Shali graham points to construction underway outside a new pandemic preparedness facility for another year or two renew community that has not actually ideas to have extra machines extra labs all on hand to make billions of doses of vaccine against whatever virus hits

India Rosa Palm Rubella Reviews Vaccine Serum Suresh Giada Serums Serum Institute Of India Shali Graham Oxford Oxford University Global Development Policy Cent Disney Golf Astra Europe England Indian Government World Trade Organization Thrashers Astrazeneca PAM
Is there a link between the AstraZeneca vaccine and blood clots?

The Naked Scientists

03:41 min | 4 months ago

Is there a link between the AstraZeneca vaccine and blood clots?

"Suspected linked to the development of a rare syndrome involving the formation of blood. Clots in the brain's blood vessels led to eighteen european countries temporarily halting their use of astrazeneca's covid nineteen vaccine pending an investigation. By the way the european medicines agency the itself though while it investigates is urging nations to continue to use the vaccine which has been so far administered to over seventeen million people going to the very real threat posed by massive surges and covid nineteen cases across europe that said some countries like belgium in the uk elected. Not interrupt their vaccine. Roll outs the aura. Which regulates medicines in the uk has also carried out its own investigation reached a very reassuring conclusion. Our view shows that there is no difference. That blood clots in veins are occurring more than would be expected in the absence of vaccination for either vaccine we have also received five reports of different a rare form of blood clot in the cerebral sinuses cerebral sinus vein thrombosis all csv t occurring together with lowered blood platelets shortly after vaccination with the covert nineteen vaccine astrazeneca. This type of blood clot can rarely occur naturally in unvaccinated people as well as in people with covid nineteen disease. A further review of these events is ongoing but a causal relationship with the vaccine has not yet been established. I'm hr hfc's june rain there. She was addressing the number ten downing street press conference earlier this week so there is still some uncertainty around this but in the end what it all comes down to is balancing risk the risk from a very rare and possibly completely unconnected medical condition versus the relatively much bigger risk of succumbing to covid nineteen infection. If you catch it and it's attendance queely so help us comprehend what is going on what we really need. Here is a professor on the public understanding of risk. Which is exactly what cambridge. University's david spiegelhalter specializes in things quite complicated. Because the story is it was ran. Last week was by blood. Clots like deep-vein thrombosis and other things and i looked to that data. What was being reported by astra zeneca. Aaron tim visits the number of Adverse reactions they didn't like anything special tool but it since come out that the actual actual real concern is from norway and germany in particular is is a particular special full of thromboses known as herbal venus sinus thrombosis associated with low platelets so this is clearly a razz syndrome and germany particular. They've at one point six million vaccines and had six seven cases of something like this and tends to be in younger women and in some so i can understand that. There is a concern about Yesterday vaccine but policymakers have to make decisions all the time. Don't they about What you're going to do and what the cost might be and what you're not going to do. And what the cost might be and it is really important not to jump the baby out with the biological bathwater because by deferring vaccination while you investigate a very remote risk of something happening you end up costing people the chance to be vaccinated in the interim one commentator in france pointed out that for every hundred thousand people. You don't vaccinate over the age of fifty four one day that will translate into five deaths. I haven't checked that statistic but it does sound plausible.

Astrazeneca European Medicines Agency UK David Spiegelhalter Vein Thrombosis Aaron Tim Belgium Sinus Thrombosis Razz Syndrome Europe Germany Cambridge Norway France
"astra zeneca" Discussed on The Economist: Babbage

The Economist: Babbage

05:53 min | 9 months ago

"astra zeneca" Discussed on The Economist: Babbage

"Be fast to get to a regulator with results were. Let's looking like a distinct possibility at the moment because we have astra zeneca is likely to apply to regulate. It's in the coming weeks when it finishes assembling data from its trials. The man in charge of trials is anthropology. We initiated the first trial on the twenty third of april since then we've vaccinated over twenty thousand people across the different countries but it wasn't as simple as just jabbing all these people. There's a lot of floor today. Because he get boosted doses of the vaccine and then we take blood tests from the regularly during the course of the trials and we stay very closely in touch with them to check how they are run to find out what's going on with the progress so for example here in the uk we all asking trouble obtuse to swap themselves every week so we get ten thousand jobs a week from them and we communicate with them every week about that so that there's just a lot of activity in running trials anticipated service. The operation initiated apps. It is crazy at the beginning with all. The vaccinations is a different crazy. Later on there have been many unsung heroes in the huge effort to create this vaccine. I'm marie salaam. Professor at degen's choose a leader programme of research into developing vaccine against break emerging pathogens. I tend to start air. So for example today i woke up about three turkey four. Am did about an hour's work. Because i couldn't sleep and got up properly at around half six came into work for about ace and then i'll leave today somewhere around six o'clock and probably take a couple of hours from then start again till ten eleven o'clock tonight..

astra zeneca marie salaam degen uk Professor
"astra zeneca" Discussed on Mornings With Gail - 1310 KFKA

Mornings With Gail - 1310 KFKA

03:18 min | 9 months ago

"astra zeneca" Discussed on Mornings With Gail - 1310 KFKA

"It's developing with astra zeneca. Well it produced a strong immune immune responses in older adults older adults among the most vulnerable to the ravages of covid. Nineteen this in an early study with key findings from the last phase of tests expected in the coming weeks results just published in the lancet medical journal. Shed more light.

astra zeneca
"astra zeneca" Discussed on The Last American Vagabond

The Last American Vagabond

04:17 min | 9 months ago

"astra zeneca" Discussed on The Last American Vagabond

"Margin of seven or less seven or less developing symptoms compared to twenty five in the control arm so apparently six of them worked six of them and that's ninety percent of that that's what they're saying by the way let's make sure this is very clear pfizer's initial group includes thirty two. That's it when it should be sixty thousand. There's success margin is seven or less developing symptoms. So if six developed symptoms or settlers or you know it would be one of them. Developed symptoms out of the seven that would be there of efficacy rate. Does that make you feel safe. So if you really strapped laid that out and if it's ninety percent and it's only seven that's one seven what does that mean for american's three million people now. I'm just pulling off the top of my head. These aren't going to translate in the way that we're talking about but understand. That is how flimsy this is. And that's why they're parading ninety percent in front of everybody because they don't think you're smart enough. They don't think any of us are smart enough to understand what this means but says the primary analyses are a bit more expanded but need to be less efficacious for success. And now we're on. Primary interim was ridiculous. Maybe maybe primary a little better. What do you think well. Now it's about sixty percent so now it went from seventy sixty percent and an astra zeneca mature enough johnson johnson and pfizer have primary analyses that distribute the vaccine to only one hundred one fifty one on fifty four one sixty four participants respectively meaning wants to fourth for pfizer. These companies state that they do not intend to stop trials after the primarily analyses. But there's every chance. I think every example every every they're saying that they're gonna tend to pursue a emergency authorization use authorization meaning that once they get that. Well then they're gonna just focus on manufacturing. Why would they keep testing if they already got. Approved is says. The second surprise from these protocols is how mild requirements for contracted covid nineteen symptoms are. So it's ninety percent effective but in way right is it. Stop you from getting sick. Apparently not as as a careful reading reveals that the minimum qualifications for case of cove nineteen is a positive pcr tests first of all so tests that has potentially ninety percent false positives according new york times is what they're using to decide if.

pfizer astra zeneca johnson johnson york times
"astra zeneca" Discussed on Monocle 24: The Briefing

Monocle 24: The Briefing

05:54 min | 11 months ago

"astra zeneca" Discussed on Monocle 24: The Briefing

"This is what really drives the changes in society, and this is the in that sense the reaction to the damage, just a symptom of that Dr Fear and anxiety and what it comes out with. A risk of research from the eighteen hundred Zurich did his interview where he said well, if we have no risk, we have terminology Khalib Room that is the definition of death. So, we are really crippling ourselves and. I hope it's going to be you know the pendulum's going to swing the other way? It's important. But at the moment I think we're very very far in this little. Anxiety driven space as a society. and. That was from Klingler. He has much more to say you can read redeem quite frequently actually in the N. that there's a longer interview with today at eighteen hundred London time here in monocle twenty four. Well, let's see to that was our editor Andrew Tucked back in London. Andrew we had a conversation even before we went on air reflecting a little bit about what of course Mr Klingler was saying but also even conversations you've been having with people in the medical community and elsewhere I guess for you. Do, we do we reach an end point, some period because you know there's been call of course for people go back to go back to work in many markets that were broadcasting to right now with with with mixed effect. As as humankind we work to season. So yeah, we did see a bit of mobilization at the back of summer going into autumn where business people Andrew thinking terms of of quarters, and even since we did this interview with Dancing Astra Zeneca saying that look at you know they're they're stopping their clinical trials right now as well and was a lot of people are putting. A lot of bets on this you know being one of these vaccine saviors that of course, a lot of politicians have been we have. A lot of the reputation on. Well it's very interesting. Isn't it because I think when we went into this pandemic, there was a huge amount of of scaremongering an unfair much of it and she turned out to be you know perhaps have a a a strand of truth that we needed to be aware of, but we certainly told here in the UK that. During, the first bout of of the pandemic, we could see five, hundred, thousand people die now that that didn't happen. So then people begin to change their behavior, they begin to see who the most vulnerable people are to this illness, and if they're not in that category, they begin to again adjust their behavior. So we're in a more interesting place and you're I spoke to somebody who is a very senior. Medical person here who is running a covert ward who said actually If you come into their hospital today unless you are seventy plus and you have a a serious health condition or your your morbidly obese, you should be able to come out of there quite soon because the treatment has changed. So rapidly in these past few months whether it's giving you blood thinners to avoid gang plots how they administer. Oxygen to you if you if you are having to take oxygen so that he was very clear that actually. The risk has completely changed and we know exactly who is at risk, but the trouble is. The society doesn't adjust in the these more nuance ways society has been set up or the government is set us up to all try move back and forth in the same in the same waves, and that is the thing is going to be very difficult hold. It was very interesting what he said about if you had an entire second lockdown with people comply because. I don't think people would not because they're beginning to become more successful understanding risk and how to mitigate both themselves and maybe people within their family or community who are more at risk. Andrew just before probably you tucked into bed last night certainly that was the case. Here in Zurich. I was looking at what was then the the lead story on a number of of UK news outlets, which was, of course we've seen numbers going up in the UK and this threat that, yes, there could be the imposition of now. More tighter measures Now whether that means you know it's going to be a blanket a blanket measures across the UK or again could it be isolated? Response been to that I mean has there been a lot of dialogue and discussion you all on the morning shows and certainly in comment this morning in the UK. Well the fear here is that nine hundred, thousand, nine year olds twenty, nine year olds a having a huge number of house policies that mingling that they've become once again, this turn the super spreaders and the the risk is they onto older people. So don't kill your granny as the kind of the government slogan to try stop you onto other senior people within your family's. So that's the risk group and I think that some of the press here is saying these terrible young people how they're behaving is very hard to keep young people. This time in their life locked up all the time and not going out to see that friends and be a bit spontaneous sometimes. So the idea is gonNA restrict again to six people who know each other in a household environment, for example. I've got feeling a lot people kind of go along with it, and in fact, many people probably haven't justed that much. But again, these things sound because you're allowed to now go to the pub with group of six people and that can be. Numerous other groups of six people in the same pub right up next to you. But you're only breaking the law if you then speak to one of the people in the other group so I didn't know it doesn't seem to make a huge amount as a sense for people in those environments. But what they're they're trying to do is lockdown the these house parties and a sense that younger people have given up on on any risk averse behaviour whatsoever. Andrew Tuck our editor in chief in. London thanks very much. You're listening to the briefing on monocle twenty four. Now staying in London you Goffin is here with today's headlines. Thanks Tyler, Astra Zeneca has -sposed final clinical trials for Corona virus vaccine is the unexplained of participants in the UK..

UK Andrew Tuck London Zurich anxiety Astra Zeneca Dancing Astra Zeneca Klingler Mr Klingler editor editor in chief Tyler Goffin
"astra zeneca" Discussed on Breaking Biotech

Breaking Biotech

04:42 min | 1 year ago

"astra zeneca" Discussed on Breaking Biotech

"All of this is to say that we're still kinda left wanting on whether or not. The Astra Zeneca vaccine is able to mount a robust CD eight memory t cell response. But. I will say that it is encouraging that we're seeing some kind pb M. C. response when it comes to interferon gamma release, but we still don't know whether that's going to lead to long term protection against SARS coke tuned factions. So unfortunately, we don't really have an answer on whether one is better. I would say this is pretty much push between modern and Astra Zeneca, and the reason for that is we don't know whether or not. Any of this response that we're seeing here is due to a CD a response or. or a CD for response, if it's only a CD four response than it's very similar to the Journal vaccine. If it's only a a response I would say that it's actually better than the maternal vaccine, but without those details and because they only did PBS's generally we don't really have an idea and maybe I'm wrong on this. So somebody's read the paper to some extent and I've missed something. Please let me know because that would change my opinion here on whether or not one is better than the other but. In terms of sort of future catalysts that are coming for this, they're doing face to in three trial in the UK with up to ten thousand patients and the recruiting for them. The first data she come in h two, twenty twenty, and then they're also doing trials in South Africa Brazil, and the United States, and this data they're saying should come in the second half of this year as well. So it really looks like at the second half of this year, we're going to get the data and then maybe an early twenty twenty. Twenty one, we're going to have some vaccines that are going to be distributed and ready to go, and specifically, I'd say the benefit to Astra Zeneca here is that because there's such a Juggernaut, they have the ability to streamline this very quickly. So they've already mentioned here that they have the manufacturing down with a heck tunein three cell line ready to produce yields of thousands of doses per leader of bio reactor material. So they're going to very quickly be able to get lots of doses of this vaccine ready to go for patients. One thing I've not really talked about is their cocktail of neutralizing antibodies for the treatment of Kobe nineteen. But that to me, that's not really as interesting the vaccine. So look into that in your own time if you're interested, but the the vaccine definitely has potential and really what I. Think we're GonNa see his approval of both of these vaccines and both maternal and Astra Zeneca probably GonNa get the green light to distribute them in the world and we'll see how that goes. But like I mentioned the beginning, I'm not going to take a position Astra Zeneca nor am I gonNa Take Madonna. It's funny to me that maternal was at around half of the market CAP. As Astra, Zeneca given the Madeira makes no money. In, Astra Zeneca generated six billion dollars in Q..

Astra Zeneca twenty twenty Astra interferon Juggernaut UK PBS Kobe South Africa United States Brazil
"astra zeneca" Discussed on Sawbones: A Marital Tour of Misguided Medicine

Sawbones: A Marital Tour of Misguided Medicine

05:03 min | 1 year ago

"astra zeneca" Discussed on Sawbones: A Marital Tour of Misguided Medicine

"We don't WANNA put any more in you than we have to. So we start with like a couple of different levels of doe scene, and then we see like okay, the low the lowest one that still worked so that's the one we'll go with God. So, the modern vaccine is moving into phase three trials. Which is great? That's the last of the clinical phase and that's very exciting, and it is an ornate vaccine which would be our first one. That we would regularly use which is pretty cool. There's also one from Pfizer. That is an Ra vaccine There is a DNA vaccine from a no vio that is pretty far along as well not quite as far as these other ones, but right now they're trying to figure out. It's harder to get DNA into the cell than it is aren a so that's one of the one of the things that you have to like. Use an electric pulse with it to get it into your cells. Yeah and there are other things there are other. You've probably heard a lot about the Oxford vaccine. The Astra Zeneca Slash Oxford vaccine. I've been paying like. Super duper close attention. I probably have heard of them. So this one does not. It does not use this method. We just described. It actually uses another virus and add a form of Adenovirus which is a cold virus basically. Uses that to deliver the code for the spike protein to the cells, and this is a whole other way of making vaccines that we haven't. You know used widely in the public yet, but has been again. The science of it is more recent, but you take a harmless virus or one that can't replicate. So, it can't cause an infection and you use it to deliver. Like it's like a secret spy. It comes in and delivers the payload of. You know Aren A and then. Goes way well, then you make spike protein So that was pretty far along the the only other one is a Novak's vaccine. just recently got some because it was further along. And it's got a protein sub unit, so it's just it's more similar to what we've talked about before a piece of a virus. That you WANNA, send in trigger an immune response with so not as exciting, but tried and true method. We know the vaccines work that way because we have some that already walk that way question. Why is it if this is that? This is a very dire situation. Right now need stuff to. Happen now. Why are we getting creative with this vaccine? Why? Why? Why? Now? Why not do something that? We like no works. That is exactly the question I was hoping you'd ask. Oh Wow, that's perfect. That's perfect. Because there are, there are many many vaccines in various preclinical and clinical phases that are using the old sort of quote, unquote tried and true methods right. The reason that are in a would be used for something. This serious is, and we've known this for a while an RNA vaccine one. We can make the vaccine a lot faster. The Madonna vaccine was like created really quickly in the grand scheme vaccine making..

Astra Zeneca Slash Oxford Pfizer Novak
"astra zeneca" Discussed on Bloomberg Radio New York

Bloomberg Radio New York

01:30 min | 2 years ago

"astra zeneca" Discussed on Bloomberg Radio New York

"From Bloomberg television. Here's Tom MacKenzie. The chairman of Astra Zeneca Leif Johansson joining us. Let's focus on China because China has been such a big component for sales for AstraZeneca in the last few years. How is it shaping up the market for twenty nine thousand volumes of sales you targeting for this year? We are we have done very well, and we have had very good growth rates. So in two thousand eighteen we grew by twenty eight percent. And we would we look at when we look ahead, which is a market very interested in in new drugs government, the system that would want them to establish a high quality healthcare, then I think all the criteria therefore good continued growth. So in line with twenty eighteen and increases twenty eight central Illinois. We never give forecast like that on on on the individual country. But I think the criteria the boundary deteriorate what we are doing. It looks very good. Are you concerned about the economic slowdown in China and the impact that may have on your business? If I am in in a broader business sense, certainly, but I think in the case of the former company, basically, we are not impacted very much by economic cycles. Much more impacted by life-science cycles medicinal cycle. And Dan, I think everything looks good. Hear more interviews. Like this one on Bloomberg television, streaming live on Bloomberg dot com and on the Bloomberg mobile app or check your local cable listings. Global.

Bloomberg China AstraZeneca Tom MacKenzie Leif Johansson chairman Illinois Dan twenty eight percent
"astra zeneca" Discussed on BizTalk Radio

BizTalk Radio

01:30 min | 3 years ago

"astra zeneca" Discussed on BizTalk Radio

"Transports up two. Oh, six today. Sometimes, you know, I try to ask myself. Why why would that be an answer? I don't know which just letting you know that the transports broke out a range today. Out of maybe can call it a quasi Cup and handle. The high was eleven four to three back in January close today at eleven five four seven strengthened rails, strengthen transportation, logistics. Strengthened some of the airlines as we have mentioned on this show. I gotta believe that's important for the market. And I'm actually surprised the Dow was down fifty something in the transports were up two hundred. So just letting you know. Managed care has been strong. I'm going to see what happens going forward. Today. I would call it a shot across the bow. Drug stocks. Look at a BT go look at Merck seriously. Golic advisor. Go look at Johnson and Johnson. Ladas is good. But better go look at Astra Zeneca AZN the truck stocks act. Well, now, the problem with the drug stocks. There's no growth there. Slow boats. But.

Astra Zeneca Johnson Ladas Merck advisor
"astra zeneca" Discussed on WLOB

WLOB

01:55 min | 3 years ago

"astra zeneca" Discussed on WLOB

"Us troops will head to afghanistan this spring usarmy will deploy roughly eight hundred additional soldiers to afghanistan in april us officials tell fox the additional troops will increase us involvement in afghanistan to about fifteen thousand troops the new troops will specialize in training the afghan military which has been decimated in recent years attempting to repel taliban gains more us jets will also head to afghanistan in the coming weeks as the ward against isis winds down in iraq and syria the top american commander in afghanistan says more us troops will be closer to the front lines to call in airstrikes on the taliban and an isis affiliate at the pentagon lucas tomlinson fox news this state of illinois and a suburban chicago school district are being sued over the use of medical marijuana for an 11yearold girl but parents of an omega3 school student suffering from leukemia seizure disorders and epilepsy or serena schaumburg based school district during the illinois over the right to use medical marijuana at school currently illegal under state law chicago tribune reports of the plaintiffs identified only by initials contend the state's ban on taking the drug at school is unconstitutional the district says it's following state law but will comply with the outcome of the suit which could set a legal precedent in chicago jeff men are so fox new and you weapon in the fight against breast cancer targeting a specific group of patients the fda approving the first drug for women with advanced breast cancers caused by an inherited flawed at jean anne who already undergone in chemotherapy the drug made by astra zeneca is part of a new class of medicines originally for ovarian cancer wall street right now a rally continues the dow is up two hundred two points at twenty five thousand seven seventy seven yes and p and nasdaq also in record territory brady fast newsradio.

jean anne fda chicago chicago tribune serena schaumburg leukemia lucas tomlinson pentagon isis Us astra zeneca fox breast cancer state law marijuana chicago school district illinois taliban commander syria iraq afghanistan
"astra zeneca" Discussed on Biden's Briefing

Biden's Briefing

02:42 min | 3 years ago

"astra zeneca" Discussed on Biden's Briefing

"About twothirds of terminal cancer patients without and approved immunotherapy option but prasong says that isn't stopping physicians from prescribing the drugs anyway hype has encouraged rampant off label use of checkpoint inhibitors as a lastditch effort he says even for patients with tumorous that show no evidence they'll respond to the drugs the antibodies were available off the shelf but at a list price near one hundred fifty thousand dollars per year it's an investment prasong says doctors shouldn't encourage lightly especially when there's no reliable way predicting who will respond and who won't this thwarts one of the goals of cancer care says preside when you run out of helpful responses how do you help a patient navigate what it means to die well merck and squibb have dominated this first wave immunotherapy selling almost nine billion dollars worth of checkpoint inhibitors since they went on sale in 2015 roche astra zeneca novartis ally lilley abbvie and regenerate on have all since jumped in the game spending billions on acquiring biotech startups and beefing up inhouse pipelines and eight hundred clinical trials involving a checkpoint inhibitor are currently underway in the us compared with about two hundred in 2015 this is not sustainable genentech vp of cancer immunology ira melhman told the audience at last year's annual meeting of the society for immunotherapy of cancer with some many trials he said the industry was throwing every checkpoint inhibitor combination at the wall just to see what would stick after more than a decade stretching out the promise of checkpoint inhibitors patients and businesses were ready for something new and this year they got it car t cell therapy the immunotherapy involves extracting a patients tcells and genetically rewiring them so they can more efficiently home in on tumors in the body training a foot soldier as an assassin that can slip behind enemy lines in september the fda cleared the first car teeth therapy treatment for children with advanced leukemia developed by novartis which made history as the first ever gene therapy approved for market a month later the agency approved another live cell treatment developed by kite pharma for a form of adult lymphoma in trials for the lymphoma drug fifty percent of patients saw their cancer disappear.

prasong lilley abbvie us vp leukemia squibb roche astra zeneca genentech fda one hundred fifty thousand dol nine billion dollars fifty percent
"astra zeneca" Discussed on KBNP AM 1410

KBNP AM 1410

02:22 min | 4 years ago

"astra zeneca" Discussed on KBNP AM 1410

"Nikai trade little bit softer today not much down by detectable upset but up to such a big pulp higher it's a significant believe us 10 years yielding two point three one tax remains the overriding story and in germany with a huge current account surplus just kind of just goes higher and higher higher the numbers are amazing the german ten years duly points three to seven eight man it's interesting also if you look at the gainers in the market are really for the most part those who haven't been putting out earnings today here hs gbah is it gainer we have banco santander dare astra zeneca bnp your actually i think it does have earnings today but yeah kelly where he put them out but his this is kind of the update just to say might the euro's just beginning to pulp a little bit hard training 88 51 now on eurosterling so did the losers are the ones that did come out for continental as gainer right now but you see see it's down two percent he's he added us down two percent of uh uh of european earnings out this morning on a focusing on a few them with benedikt cobble editor of global the berlin studio benny let's kick it off with zeman's um it's the second biggest loser well i have my moves in terms of index plots so it's the second biggest loser in terms of index points down more than two percent though on the dow what's going on there joe qaiser says he's planning sweden at the engineering companies power and gas business in setting the stage for a turnaround plan but investors want to sell us stock today yes that's right so cements as a bit of a bellwether for the german and european manufacturing in mystery that are in so many different areas of factory equipment power generation so as a closely ceo morning and said as you say some sweeping cuts planned at the power unit the problem there is that you till that he's just on buying this ultra expensive massive equipment and the way that they use to a couple of years ago the the super cycle seems to be coming to to to an end here and and that means they have to adjust the factories and there's a big factory here in berlin actually makes big turbines and what will probably see in the next couple some pretty painful cuts happening at these facilities and so.

banco santander kelly editor zeman joe qaiser sweden germany astra zeneca berlin benny ceo two percent ten years 10 years
"astra zeneca" Discussed on WGN Radio

WGN Radio

01:53 min | 4 years ago

"astra zeneca" Discussed on WGN Radio

"We shouldn't be going to our dr insane paying i'd like to try some ball top right we sleep suggesting in the ads you should try this year i think you might want to try and then you and your wife can take baths next to each other in a garden every time i would say we'll whose cantu bathtubs in their garden well they for the enhancement talking about just any like even allergy medications are room attack but rheumatoid arthritis you shouldn't be going i i just find that is why that it's not like it's chocolate elite various kinds of chocolate these are drugs but they go you might want to try this and all my god the possible sideeffects is longer than the actual i know bath and you know what he is now if things go well what's funny is a lot of times the side effects are are exactly what you taking that drug four or even worse yeah you know so you go i don't want to take a chance on those things just for this i dunno i just know that there was an adhd mad that was a non stimulants and when i saw that i'm like oh i don't want my kids taking stimulants they had been on adhd madson secondgrade when in and asked my doctor about this and they said yeah well we can try that turned out to be completely the wrong medication and then i was mad at myself right for suggesting that right right so i don't think drugs should be advertisement periods yes i do like when they say at the end of an ad in it's always for various is some sort of a drug that can help you in some way they say that astra zeneca could help like if you're thinking about getting this but you can't afford it astra zeneca can help because to me that sounds like somebody from battle star galactic at i cut so cool that there was like the help i was sad astrazeneca was a bad guy but no that he wants to help you so he's a good guy all right we'll take a break steve has the news and that after the news dana gould hysterically funny will be joining us live in studio stick around its bone when he wgn listening.

adhd astra zeneca steve madson dana gould
"astra zeneca" Discussed on KARN 102.9

KARN 102.9

01:37 min | 4 years ago

"astra zeneca" Discussed on KARN 102.9

"Look at people with cancer and pot about twenty five percent of the patient survey to seattle cancer center say they've used marijuana in the past year mostly for physical or psychological symptoms like paid or stress few say they're getting information about it for their cancer doctors something they want more of the study's lead author says that's concerning because marijuana can have unintended and sometimes dangerous side effects for some patients study appears of the journal cancer peter king cbs news the chaos wrought by hurricane maria on puerto rico may lead to a shortterm prescription drug shortage companies like ally lilley and astra zeneca are scrambling to assess damage to their plants on the island even though most have backup generators nearly fifty pharmaceutical companies are trying to shift manufacturing elsewhere because employees are dealing with the aftermath of the hurricane deborah rodriguez cbs news the weekend tonight partly cloudy and humid with a low sixty nine is partially sunny warm and human tomorrow with a high of eighty eight partly cloudy and humid tomorrow night low sixty eight tuesday's partially sunny warm and he would with a high of eighty nine i'm accuweather's alex rab these use mark levin the government snooping continued into early this year including a period when manner for was known to talk to president donald trump so now they're surveilling donald trump not directly at this point he's the president elect and eventually of course the president in milan manner in which there investigating this matter which they're gone after paul manafort really is truly in my view grotesque listen to mark levin evenings at six following doc washburn on news radio.

alex rab doc washburn milan mark levin peter king seattle cancer center paul manafort president donald trump cancer accuweather deborah rodriguez pharmaceutical companies astra zeneca ally lilley puerto rico marijuana twenty five percent
"astra zeneca" Discussed on KBNP AM 1410

KBNP AM 1410

02:11 min | 4 years ago

"astra zeneca" Discussed on KBNP AM 1410

"I staying with the loath lot of seven stamps dot com cabot microelectronics for tech's pharmaceuticals regenerate pharmaceuticals black rock that's been rolling over six more amazon net flex watch that flicked though i think it's going to go to hundreds united but don't buy it here united therapeutics fedex as mentioned broad commas mentioned five or more was the on the fives dst systems this with the dow up a 85 nvidia aris the networks astra zeneca gap down on drug new sherwin williams that's rolling over four fina health cullen frost bankers caviar ups insight corp arch capital universal health realty jed third domino's pizza what i tell you about restaurants a domino's pizza donna a dive the last three days a old dominion freight war transportation a wiggs resorts is a four three of more than just the threes mckesson cappella occasion bear with me extra space store jamaican appoint amgen palo alto networks bluebird bio nura yet the legislation sell gene on their numbers a dopey lam research on their numbers trans dime see eight eight ecwa facts le may shop of five brunswick franklin financial grupo aeroports rather yo or something like that nor folks southern i p g photon exchange therapeutics zimmer biomet medical which dot com and star group ultimate software grand canyon in education johnson controls essex property trust northrop grumman universal display xl group their insurance fox got hit today ayaan plc more insurance tupperware union pacific american tower lou meant them that's just the three of moore's to the downside with the dow up eighty six now you wanna know what i mean by possible negative divergences to.

dow nvidia domino lam research lou moore amazon united dst systems astra zeneca sherwin williams wiggs essex northrop grumman pacific american tower three days
"astra zeneca" Discussed on Global News Podcast

Global News Podcast

02:02 min | 4 years ago

"astra zeneca" Discussed on Global News Podcast

"Nol pierce pearson an aboriginal leader from queensland believes the absence of a treaty and a genuine political voice are perpetuating this suffering is not out in amman and that all of the palace social misery of out people is linked to structural powerlessness we are the most per capita imprison people in the world now children away from their families living in foster care at greats greater than probably any human population across the face of this report by phil mercer in australia shares in the angloswedish pharmaceuticals giant astrazeneca have fallen dramatically after the company said new cancer drug could failed to live up to expectations it will set reported a sharp fall in revenues for the first half of the year his the leggett astra zeneca has been testing a combination of two immunotherapy drugs designed the treatment for lung cancer the outcome of clinical trials had been eagerly awaited by investors however initial results suggested that the treatment was no more effective than conventional chemotherapy analysts described the news as a significant blow for the company the study had been seen as a key test of astra zeneca's drug development program and vital to its future as an independent company theor leggett now when is a blue flower really blue after painstaking research the first trueblue chrysamthium has apparently been created talked to helen jaski is an expert on colors in nature the debate over what constitutes the color blue has challenged old certainties so i began my interview with dr gysky by challenging her to an impromptu test a cornflower nutley night see holly no idea blue rose doesn't exist parsinen third my gotten dolphin him uh they might easily yes.

queensland amman phil mercer leggett astra zeneca theor leggett dr gysky Nol pierce per capita australia helen jaski holly
"astra zeneca" Discussed on Bloomberg Radio New York

Bloomberg Radio New York

01:44 min | 4 years ago

"astra zeneca" Discussed on Bloomberg Radio New York

"Zeneca are down sixteen percent in london after a setback for its nextgeneration cancer therapy treatment was found to be no better than chemotherapy and treating lung tumors astra zeneca had expected it to generate more than seven billion dollars in sales over the next five years hugh uk regulators announced today that the london interbank offered rate lie bore the benchmark underpinning more than three hundred fifty trillion dollars of financial products will be phased out by the end of twenty twenty one the financial conduct authority says the radius and sustainable because of a lack of transactions providing data is a busy day for earnings has 72 company should in the s p 500 is scheduled to report amazon headlines the less than a set to release results after the close of us trading bloomberg's jeff bellinger has a preview amazon saw a big increase in the number of prime subscribers in the second quarter a yearoveryear jump of thirty five percent by one estimate that likely boosted sales and bloom berg intelligence says the sixty percent event growth on prime day and momentum for cloudbased services may help the company's thirdquarter outlook forecasts are for amazon to post a profit of adalbert forty two a share on revenue of nearly thirty seven point two billion dollars jeff bellinger bloomberg daybreak afraid he appreciated jeff weaver already heard from comcast this morning with profit the topped estimates thanks to the success of box office hits like the fate of the furious which boosted results at its film division comcast shares currently of two point four percent in early trading in germany deutsche bank reported a ten percent decline in revenue for its weakest quarter in three and a half years earnings editor reorganized investment banking unit slumped sixteen percent and deutsche bank shares are currently down three point five percent.

Zeneca london zeneca bloomberg jeff bellinger amazon jeff weaver comcast germany deutsche bank editor uk london interbank offered rate investment banking deutsche bank sixteen percent three hundred fifty trillion d seven billion dollars thirty five percent two billion dollars sixty percent five percent four percent ten percent five years